Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

5 tips to learn AI from scratch and for free
There’s no shortage of resources for healthcare workers who wish they knew AI well enough to talk shop with the technology pros who develop the models. The problem is weeding through the offerings to get to what will really work for you.
Boston Scientific TAVR valve comes up short in comparison with Medtronic, Edwards devices
The Acurate neo2 TAVR valve has been used to treat severe aortic stenosis in other parts of the world for years. In the United States, however, the device has still not been approved for commercial use.
Abbott CGM sensors can now be worn during common imaging procedures
Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.
Good AI governance can spell the difference between smashing success and mere learning experience
Discussions of AI governance may cause many an eye to glass over, but the discipline is as crucial to the ascent of AI in healthcare as big training datasets drawn from diverse patient populations.
Colchicine falls flat in large heart attack trial, convincing cardiologists to stay away
Treating AMI patients with colchicine is not associated with better cardiovascular outcomes, according to new data presented at TCT. The drug did help with inflammation, but that was the only benefit researchers could identify.

Cigna adds partners for opioid use disorder treatment

Cigna has teamed up with Bicycle Health to add coverage for virtual opioid use disorder treatment to Cigna plan customers.

August 29, 2022

Very low doses of edoxaban are safe and effective for frail, elderly AFib patients

Elderly patients are often not eligible for oral anticoagulant therapy due to the risk of bleeding events or other adverse outcomes. A very low dose of edoxaban, however, appears to be a safe treatment option, even for especially frail patients.

August 26, 2022

The Abbott Cephea transcatheter mitral valve replacement (TMVR) system.

Cardiologist praises updated design of new TMVR system after historic interventional procedure

A care team with the Sanger Heart & Vascular Institute has shared details about its recent successes in TMVR and TAVR. Cardiologist Michael Rinaldi, MD, highlighted the importance of having "a coordinated team of specialists with expertise in treating valve diseases."

August 26, 2022

Large study offers new insights on how alcohol consumption impacts cancer risk

A new study out of Korea found that an increase in alcohol consumption is linked with a higher risk for all cancers, including alcohol-related cancers.

August 25, 2022

Amazon shutting down Amazon Care at the end of the year

In a surprise move announced Aug. 24 in a memo to staff, Amazon Care will be no more come year’s end.

August 25, 2022

AI model explores EHR data to predict physician burnout

A new AI tool from Washington University in St. Louis researchers aims to help identify burnout among physicians and could potentially prevent it in the future.

August 24, 2022

NSAID use may not be safe for older patients with type 2 diabetes

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022.

August 23, 2022

Americans are facing a prescription drug debt spiral

More than 4 in 10 prescription drug medicine users are concerned that drug spending will lead to bankruptcy or debt.

August 19, 2022

Care Delivery

5 tips to learn AI from scratch and for free

Boston Scientific TAVR valve comes up short in comparison with Medtronic, Edwards devices

Abbott CGM sensors can now be worn during common imaging procedures

Good AI governance can spell the difference between smashing success and mere learning experience

Colchicine falls flat in large heart attack trial, convincing cardiologists to stay away